(Q33503385)

27 July 2017

title

Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC. (English)

1 reference

27 July 2017

1 reference

1 reference

1 reference

Isokangas OP

1

1 reference

27 July 2017

Joensuu H

2

1 reference

27 July 2017

Halme M

3

1 reference

27 July 2017

Jekunen A

4

1 reference

27 July 2017

Mattson K

5

1 reference

27 July 2017

publication date

1 May 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

20

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

127-133

1 reference

Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Controversies in the Nonsurgical Treatment of Stage III Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Taxol and ionizing radiation: interaction and mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Radiation therapy with concomitant continuous infusion cisplatin for unresectable nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Unresectable non-oat cell carcinoma of the lung: definitive radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900025-7

7 January 2021

10.1016/S0169-5002(98)00025-7

Identifiers

DOI

1 reference

27 July 2017

1 reference